ASHP reinforced its support for the 340B Drug Pricing Program during March 15 testimony before the Senate Committee on Health, Education, Labor & Pensions.
Joseph Hill, director of ASHP’s Government Relations Division, emphasized that the program helps maximize scarce federal resources while providing low-income and uninsured patients access to lifesaving medications. Hill’s testimony noted that savings from the 340B program fund critical pharmacist-provided care services such as treatment for opioid abuse, medication management services, and disease management for chronic diseases. Hill also stressed the importance of program compliance and highlighted ASHP’s efforts to ensure that covered entities use the program in a manner consistent with its purpose.
